CRV, a early-stage venture firm that made headlines for its stance on then-candidate Donald Trump’s campaign, is looking to get out a new (non-political) message: it’s diving more deeply into the business of AI-driven biotech. The move comes years after some other venture firms have taken a deep dive into biotech, including True Ventures and Andreessen Horowitz. But CRV general… Read Morevia Zero Tech Blog
